🇺🇸 FDA
Patent

US 11857641

Method for the treatment of mucopolysaccharidosis type I

granted A61KA61K38/47A61K48/005

Quick answer

US patent 11857641 (Method for the treatment of mucopolysaccharidosis type I) held by Sangamo Therapeutics, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/47, A61K48/005, A61K48/0083, A61P